TWO SIGMA ADVISERS, LP - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 72 filers reported holding IMMUNE DESIGN CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$1,722,000
+371.8%
294,400
+5.0%
0.00%
+300.0%
Q4 2018$365,000
-33.6%
280,400
+75.9%
0.00%0.0%
Q3 2018$550,000
-27.0%
159,400
-3.6%
0.00%
-50.0%
Q2 2018$753,000
+35.4%
165,400
-1.9%
0.00%0.0%
Q1 2018$556,000
+23.8%
168,600
+46.6%
0.00%
+100.0%
Q4 2017$449,000115,0000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2018
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders